Related posts
This Week’s Stock Picks & BNN Top Picks Summary: MRK-N, IONQ-N and 19 Stock and 4 ETF Top Picks (Jan 03-09)Grinch extends sell-offTSX and tech’s big weekThis summary was created by AI, based on 1 opinions in the last 12 months.
Agilent Technologies, with the symbol A-N, has received positive reviews from different experts. The company has affirmed its forecast of 5-7% annual revenue growth and steady operating margin expansion, leading to a favorable outlook. Additionally, the stock is trading at a relatively low 22x 2025 PE, which indicates potential undervaluation. Overall, experts are optimistic about the company's future performance and financial position.
Sector has been impacted with economic slow down after Covid-19. Believes healthcare sector will be strong in the long term. Lab tools in high demand globally. Will continue to own shares. Well managed company.
(Top Short July 7/05. Down 11%.) It had fallen below the 200 day moving average and every rally that we had, failed to go higher than the 200 which indicated a negative trend. Historically this stock has an up tick at year end, but will then fall again.
Agilent Technologies is a American stock, trading under the symbol A-N on the New York Stock Exchange (A). It is usually referred to as NYSE:A or A-N
In the last year, 1 stock analyst published opinions about A-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Agilent Technologies.
Agilent Technologies was recommended as a Top Pick by on . Read the latest stock experts ratings for Agilent Technologies.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Agilent Technologies In the last year. It is a trending stock that is worth watching.
On 2025-01-10, Agilent Technologies (A-N) stock closed at a price of $137.47.
It just affirmed its forecast of 5-7% annual revenue growth and steady operating margin expansion. Trades at only 22x 2025 PE.